February 2022

How vaccines affect the risk of cardiac, respiratory issues | The FDA's busy week | Medicare reform ()
February's 10 biggest stories: Cardiac MRI | Late-breaking clinical trials | A key FDA approval | New CDC guidance ()
The future of echocardiography | The economics of TAVR | Cardiologist gets jail time for abusing infant son ()
Week in Review: New meds and technologies that could transform cardiology | Limiting vaccine-related heart damage ()
Prevention & Risk Reduction: The potential harms of acetaminophen | Recurrent stroke & marijuana ()
FDA approves empagliflozin for HFpEF | CDC's new guidance on vaccine-related myocarditis | Recurrent MR after TEER ()
Breaking News: FDA approves empagliflozin for HFpEF ()
A potential new treatment for MIS-C | Eating vegetables does little to prevent CVD | Amyloidosis & TAVR ()
Vascular & Endovascular: Directional atherectomy systems recalled | When heart attack patients need PCI ()
AstraZeneca COVID vaccine increases blood clot risk | Abbott's latest FDA approval | On-pump vs. off-pump CABG ()
Interventional & Surgery: Heart Team consultations lead to better patient outcomes | New data on left main PCI ()
4 medications & technologies that could transform cardiology in 2022 | Electrophysiologists debut new tech ()
Week in Review: New data on vaccine-related myocarditis | Cardiologist to run FDA | EECP for long COVID ()
Economics & Policy: Hospital pays $3.8M to resolve allegations | Boston Scientific's $1.75B deal ()
76% of world’s BP monitors have not been validated | CMR predicts sudden cardiac death in CIED patients ()
Boston Scientific finalizes $1.75B acquisition | Best of KLAS 2022 | Cardiologist accused of sexual assault ()
Heart Failure: Implantable atrial shunt therapy | Empagliflozin & hospitalizations | Metformin boosts outcomes ()
CMR & vaccine-related myocarditis | Cardiologist confirmed as FDA commissioner | Heart teams make an impact ()
Breaking News: Senate confirms cardiologist Robert Califf as next FDA commissioner ()
Hospital pays $3.8M to resolve allegations | EECP & long COVID | Mortality after TEER | ACC NCDR enrollment ()
Heart Rhythm: The first implant of a dual-chamber leadless pacemaker | FDA clears Holter monitor for low-risk patients ()
Week in Review: What to expect at ACC.22 | Medtronic's latest recall | The risks of daily acetaminophen use ()
Recurrent stroke & marijuana use | Heart drug at center of Olympics controversy | Getinge's big acquisition ()
TAVR: An effective treatment for asymptomatic patients | Sapien 3 Ultra THV outperforms its predecessor ()
TEE & cardiac surgery | Merger worth $2.4B called off due to ‘unfavorable market conditions’ ()
Daily acetaminophen use may be bad for hypertension patients | Late-breaking clinical trials at ACC.22 ()
COVID's long-term impact on the heart | Abbott announces first implant of dual-chamber leadless pacemaker ()
Structural Heart Disease: Same-day discharge after LAAO | TAVR in asymptomatic patients | TEER's value ()
Medtronic recalls another interventional device | TV annuloplasty during MV surgery ()
Acute Coronary Syndromes: Vitamin D supplements & CVD | Rural heart attack patients during the pandemic ()
Heart rate abnormalities & COVID-19 | A clinician's guide to revascularization techniques among women ()
Week in Review: Same-day discharge after LAAO | A tragedy in Minnesota | Time of day & TAVR outcomes ()
Imaging & Physiology: A new tool for evaluating CVD risk | FDA clears cardiac mapping solution ()
When risk of COVID-related stroke is highest | Cardiologist dies after small plane crash ()
COVID-19: Lingering heart issues after mild cases | Vaccine-related myocarditis | RV dysfunction ()
Heart issues seen in 41% of Americans during pandemic | Same-day discharge after LAAO ()
Practice Management: Burnout hitting cardiology less than other specialties | COVID-19's continued impact ()
Time of day & TAVR outcomes | New data on the link between diabetes & high blood pressure ()